Magnetically Controlled Capsule Endoscopy First vs. Standard Algorithm in Patients With Melena — FIRM

Melena Clinical Trial

Official title:
Magnetically Controlled Capsule Endoscopy First vs. Standard Algorithm in Patients With Melena (FIRM Trial): a Multicenter, Randomized Controlled Trial

Status Withdrawn

Clinical Trial Summary

MCE first algorithm is not inferior to standard of care algorithm in terms of further bleeding in hemodynamically stable patients with acute overt and non-hematochezia GI bleeding.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Melena

Clinical Trial Details

NCT number	NCT04019067
Study type	Interventional
Source	Changhai Hospital
Contact
Status	Withdrawn
Phase	N/A
Start date	December 1, 2020
Completion date	September 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00389935` - Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding	Phase 2
Completed	`NCT00534677` - The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed	Phase 4
Active, not recruiting	`NCT01863303` - Epidemiological Study of Colorectal Cancer in WuHan	N/A
Completed	`NCT03028064` - Point of Care Testing of Platelet Function in Patients With Acute Upper Gastrointestinal Bleeding
Completed	`NCT03955055` - Study of Early Endocapsule (EC) in Clinical Decision Unit Versus Standard of Care Work-up for GI Bleeding	N/A
Completed	`NCT02442830` - Comparing Early Capsule Deployment to Current Standard of Care for Management of Gastrointestinal Bleeding	N/A
Not yet recruiting	`NCT01371591` - Capsule Endoscopy for Hemorrhage in the Emergency Room	N/A